(Q51187346)

1 April 2018

title

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. (English)

1 reference

1 April 2018

author

David W. Denning

1

1 reference

1 April 2018

Nita L Seibel

8

object named as

Nita L Seibel

1 reference

1 April 2018

Thomas F Patterson

12

object named as

Thomas F Patterson

1 reference

1 April 2018

Kieren A Marr

2

object named as

Kieren A Marr

1 reference

1 April 2018

author name string

Wendi M Lau

3

1 reference

1 April 2018

David P Facklam

4

1 reference

1 April 2018

Voravit Ratanatharathorn

5

1 reference

1 April 2018

Cornelia Becker

6

1 reference

1 April 2018

Andrew J Ullmann

7

1 reference

1 April 2018

Patricia M Flynn

9

1 reference

1 April 2018

Jo-Anne H van Burik

10

1 reference

1 April 2018

Donald N Buell

11

1 reference

1 April 2018

language of work or name

1 reference

6 May 2006

1 reference

1 April 2018

number of pages

13

1 reference

inferred from page(s)

published in

Journal of Infection

1 reference

1 April 2018

volume

53

1 reference

1 April 2018

issue

5

1 reference

1 April 2018

page(s)

337-349

1 reference

1 April 2018

maintained by WikiProject

WikiProject Medicine

0 references

cites work

Disseminated aspergillosis in intensive care unit patients: an autopsy study

1 reference

12 December 2020

Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

Invasive aspergillosis in critically ill patients without malignancy

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

12 December 2020

Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients

1 reference

12 December 2020

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

1 reference

12 December 2020

Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach

1 reference

12 December 2020

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis

1 reference

12 December 2020

Death of a SARS case from secondary aspergillus infection.

1 reference

12 December 2020

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

1 reference

12 December 2020

Combination antifungal therapy

1 reference

12 December 2020

Infliximab for steroid‐refractory acute GVHD: A case series

1 reference

12 December 2020

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

1 reference

12 December 2020

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

12 December 2020

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

1 reference

12 December 2020

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin

1 reference

12 December 2020

The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants

1 reference

12 December 2020

Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis

1 reference

12 December 2020

Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management

1 reference

12 December 2020

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

1 reference

12 December 2020

Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants

1 reference

12 December 2020

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

1 reference

12 December 2020

Therapeutic outcome in invasive aspergillosis

1 reference

12 December 2020

Echinocandin antifungal drugs

1 reference

12 December 2020

Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.

1 reference

12 December 2020

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis

1 reference

12 December 2020

Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent

1 reference

12 December 2020

A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan

1 reference

12 December 2020

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

12 December 2020

Micafungin: a therapeutic review

1 reference

12 December 2020

Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.

1 reference

12 December 2020

A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients

1 reference

12 December 2020

Invasive Aspergillosis in Italian AIDS patients

1 reference

12 December 2020

A 7-year study of severe hospital-acquired pneumonia requiring ICU admission

1 reference

12 December 2020

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

12 December 2020

A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis.

1 reference

12 December 2020

Aspergillosis. Pathogenesis, clinical manifestations, and therapy

1 reference

12 December 2020

Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus

1 reference

12 December 2020

Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant

1 reference

12 December 2020

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

12 December 2020

10.1016/J.JINF.2006.03.003

Identifiers

DOI

1 reference

1 April 2018

0 references

1 reference

1 April 2018